China Regenerative Medicine International Ltd. said Wang Xuejun will serve as CEO and an executive director, effective Sept. 3.
Wang will also serve as CEO at the company's stem cell division. He replaces Chen Chunguo, who resigned in July. Wang previously held executive roles at Vcanbio Cell & Gene Engineering Corp. Ltd., Union Stemcell & Gene Engineering Co. Ltd. and certain units of Heze Biotechnology Co. Ltd.
Additionally, China Regenerative Medicine appointed Ray Yip to serve as chief medicine officer and Zhang Jinnan as chief technology officer.
Yip joined the company's board in February 2017, and was named an executive director in September that year. Zhang was assistant to CEO of China Regenerative Medicine, and deputy general manager of Shenzhen Ainear Cornea Engineering Co. Ltd.
Hong Kong-based China Regenerative Medicine develops biomedical and healthcare products, as well as medical techniques.